Clinical outcome of sars-cov-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab

HIGHLIGHTS

  • who: Andrea Duminuco and colleagues from the Health Agency of Cosenza, ItalyDipartimento di Scienze Biomediche e Biotecnologie Avanzate, University of Catania, Catania, Italy have published the research: Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab, in the Journal: (JOURNAL) of 15/04/2020
  • what: This is an open-access article use distribution or reproduction in other forums is permitted provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited in accordance with . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?